Found 4 matching trials
A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors PHASE1 A Phase I/II, Open-Label, Dose-Escalation and Dose-Expansion Clinical Study...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer PHASE2 To evaluate the efficacy and safety of LM108 plus toripalimab plusnab-pacli...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma PHASE3 This is a phase III, Multicenter, Randomized study, evaluating the efficacy...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours PHASE2 Based on overall response rate (ORR) as assessed by the Independent Review ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial